METHOD FOR PREDICTION OF LENGTH OF ARTIFICIAL PULMONARY VENTILATION IN PATIENTS WITH SEVERE GUILLAIN-BARRET DISEASE

摘要

FIELD: medicine.;SUBSTANCE: patient's blood serum is examined for tau protein and glial fibrillary acidic Protein. If the first value is more than 114 pc/ml and the other value is more than 0.2 pc/ml respectively, a long, min. 8-day APV requiring application of tracheostoma is predicted. If the first value is 114 pc/ml or less, and the other value is 0.2 pc/ml or less, APV is predicted for a number of days 2 to 7 requiring no tracheostoma.;EFFECT: method enables fast and accurate diagnosing the length of artificial pulmonary ventilation.;2 ex